glp 1 agonists addiction Frontiers Glucagon-like peptide-1 receptor agonists and

Rita Kapoor Explain the Timeline for Appetite Suppression and Weight Loss.

Humana blocks Wegovy for weight loss using automated diagnosis code editsnot PA denials

Simple Comparison between upcoming Monthly GLP-1s: By Amgen and Pfizer The Monthly Obesity Treatment Race Is Heating Up The next wave of obesity pharmacotherapy may not be about achieving greater efficacy aloneit may also be about achieving it with less frequent dosing

GLP-1/GIP Therapy Discontinuation: Why the How Matters One of the most-discussed challenges with GLP-1/GIP agonists such as tirzepatide (Mounjaro) is weight regain after stopping therapy

Insulin and incretins are compounds with multiple effects on neurodegenerative processes

Their potential for disease modification and symptom relief, particularly in specific phenotypes, supports their further exploration as part of a personalized treatment approach.